INTEGRATED CORE STRATEGIES (US) LLC - 04 Feb 2026 SCHEDULE 13G Report for Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI)

Filing Manager
INTEGRATED CORE STRATEGIES (US) LLC
Reporting Manager
Millennium Management LLC
Security
Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share
Symbol
KPTI
Shares outstanding
18,339,309 shares
Disclosed Ownership
1,008,662 shares
Ownership
5.5%
Form type
SCHEDULE 13G
Filing time
10 Feb 2026, 16:48:45 UTC
Date of event
04 Feb 2026
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Integrated Core Strategies (US) LLC 5.4% 997,577 0 997,577 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Management LLC 5.5% 1,008,662 0 1,008,662 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 5.5% 1,008,662 0 1,008,662 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 5.5% 1,008,662 0 1,008,662 /s/ Israel A. Englander Israel A. Englander